Richard Agnes
Title
Cited by
Cited by
Year
Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine
G Griebel, DC Blanchard, RS Agnes, RJ Blanchard
Psychopharmacology 120 (1), 57-66, 1995
1311995
Conformation–activity relationships of opioid peptides with selective activities at opioid receptors
VJ Hruby, RS Agnes
Peptide Science 51 (6), 391-410, 1999
1141999
Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?
Y Cheng, JD Meyers, RS Agnes, TL Doane, ME Kenney, AM Broome, ...
Small 7 (16), 2301-2306, 2011
912011
Peptide‐Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer
JD Meyers, Y Cheng, AM Broome, RS Agnes, MD Schluchter, ...
Particle & Particle Systems Characterization 32 (4), 448-457, 2015
872015
Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors
W Zhang, S Gardell, D Zhang, JY Xie, RS Agnes, H Badghisi, VJ Hruby, ...
Brain 132 (3), 778-787, 2009
842009
Suborganelle sensing of mitochondrial cAMP-dependent protein kinase activity
RS Agnes, F Jernigan, JR Shell, V Sharma, DS Lawrence
Journal of the American Chemical Society 132 (17), 6075-6080, 2010
652010
Deep quench: an expanded dynamic range for protein kinase sensors
V Sharma, RS Agnes, DS Lawrence
Journal of the American Chemical Society 129 (10), 2742-2743, 2007
562007
Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
RS Agnes, YS Lee, P Davis, S Ma, H Badghisi, F Porreca, J Lai, VJ Hruby
Journal of medicinal chemistry 49 (10), 2868-2875, 2006
522006
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
VJ Hruby, RS Agnes, P Davis, SW Ma, YS Lee, TW Vanderah, J Lai, ...
Life sciences 73 (6), 699-704, 2003
492003
Design and synthesis of novel hydrazide-linked bifunctional peptides as δ/μ opioid receptor agonists and CCK-1/CCK-2 receptor antagonists
YS Lee, RS Agnes, H Badghisi, P Davis, S Ma, J Lai, F Porreca, VJ Hruby
Journal of medicinal chemistry 49 (5), 1773-1780, 2006
452006
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain
KE Hanlon, DS Herman, RS Agnes, TM Largent-Milnes, IR Kumarasinghe, ...
Brain research 1395, 1-11, 2011
382011
An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor
RS Agnes, AM Broome, J Wang, A Verma, K Lavik, JP Basilion
Molecular cancer therapeutics 11 (10), 2202-2211, 2012
372012
New paradigms and tools in drug design for pain and addiction
VJ Hruby, F Porreca, HI Yamamura, G Tollin, RS Agnes, YS Lee, M Cai, ...
The AAPS journal 8 (3), E450-E460, 2006
362006
Photochemically-activated probes of protein-protein interactions
SK Nandy, RS Agnes, DS Lawrence
Organic letters 9 (12), 2249-2252, 2007
302007
Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptors
YS Lee, J Nyberg, S Moye, RS Agnes, P Davis, S Ma, J Lai, F Porreca, ...
Bioorganic & medicinal chemistry letters 17 (8), 2161-2165, 2007
302007
Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors
YS Lee, RS Agnes, P Davis, S Ma, H Badghisi, J Lai, F Porreca, VJ Hruby
Journal of medicinal chemistry 50 (1), 165-168, 2007
272007
Novel design of bicyclic β-turn dipeptides on solid-phase supports and synthesis of [3.3. 0]-bicyclo [2, 3]-Leu-enkephalin analogues
X Gu, J Ying, RS Agnes, E Navratilova, P Davis, G Stahl, F Porreca, ...
Organic letters 6 (19), 3285-3288, 2004
242004
Structure–activity relationships of bifunctional cyclic disulfide peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
RS Agnes, J Ying, KE Kövér, YS Lee, P Davis, S Ma, H Badghisi, ...
Peptides 29 (8), 1413-1423, 2008
212008
Design of peptide agonists.
VJ Hruby, RS Agnes, C Cai
Methods in enzymology 343, 73, 2002
112002
Molecular Imaging of Tumors Using a Quantitative T1 Mapping Technique via Magnetic Resonance Imaging
K Herrmann, ML Johansen, SE Craig, J Vincent, M Howell, Y Gao, L Lu, ...
Diagnostics 5 (3), 318-332, 2015
102015
The system can't perform the operation now. Try again later.
Articles 1–20